Anders Lennart Bladh
Chairman at DISTIT AB
Net worth: 30 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Per Johan Kaufmann | M | 68 | 2 years | |
| Per Andersson | M | 57 | 18 years | |
| Carl Torbjörn Bäckström | M | 76 |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | 18 years |
| Ann Åsén | F | - |
Intervalor AB
 Intervalor AB Investment ManagersFinance Intervalor AB is a private company that provides trustee services in Denmark and Norway. The company is based in Stockholm, Sweden. The Swedish company's focus is on managing assets for its clients. It has reference customers and can be contacted through its website. The company was founded in 1992 by Anders Lennart Bladh, who has been the CEO since then. | 3 years |
| Kerstin Hasselgren | F | 63 | 5 years | |
| Charlotte Gaarn Hansson | F | 62 | 12 years | |
| Magnus Doverskog | M | - |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | - |
| Christine Lind | F | 50 | 5 years | |
| Lennart Richard Låftman | M | 79 |
Intervalor AB
Intervalor AB Investment ManagersFinance Intervalor AB is a private company that provides trustee services in Denmark and Norway. The company is based in Stockholm, Sweden. The Swedish company's focus is on managing assets for its clients. It has reference customers and can be contacted through its website. The company was founded in 1992 by Anders Lennart Bladh, who has been the CEO since then. | - |
| Mikael Nilsson | M | 48 | 3 years | |
| Anna-Karin Ekberg | F | - | 2 years | |
| Thomas Walz | M | - | 2 years | |
| Robert Molander | M | 59 | 2 years | |
| Tomas Fallman | M | 59 | 2 years | |
| Hans Christopher Toll | M | 56 |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | 3 years |
| Michael af Winklerfelt | M | 52 | - | |
| Fredrik Ydevall | M | - |
Intervalor AB
Intervalor AB Investment ManagersFinance Intervalor AB is a private company that provides trustee services in Denmark and Norway. The company is based in Stockholm, Sweden. The Swedish company's focus is on managing assets for its clients. It has reference customers and can be contacted through its website. The company was founded in 1992 by Anders Lennart Bladh, who has been the CEO since then. | 4 years |
| Martin Gutberg | M | - | - | |
| Edward Jordan | M | 55 | 1 years | |
| John Öhd | M | 53 |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | - |
| Lars Erik Nyberg | M | 79 |
Intervalor AB
Intervalor AB Investment ManagersFinance Intervalor AB is a private company that provides trustee services in Denmark and Norway. The company is based in Stockholm, Sweden. The Swedish company's focus is on managing assets for its clients. It has reference customers and can be contacted through its website. The company was founded in 1992 by Anders Lennart Bladh, who has been the CEO since then. | 11 years |
| Thomas P. Blackburn | M | - |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | 7 years |
| Torbjörn Mattias Koivisto | M | 55 | 7 years | |
| Bruce F. Scharschmidt | M | 78 |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | 8 years |
| Charlotta Liljebris | M | 60 | 6 years | |
| Anders Olof Adolf Ekblom | M | 70 | 2 years | |
| Carl-Johan Spak | M | 68 | 9 years | |
| Anders Eric Karlsson | M | 59 |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | 2 years |
| Viktor Drvota | M | 59 |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | 8 years |
| Maris Gunars Hartmanis | M | 71 | 9 years | |
| Andreas Konar | M | 75 | 14 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Arne Myhrman | M | 70 | 7 years | |
| Robert Rosenzweig | M | 57 | 6 years | |
| Nils Jonas Mårtensson | M | 61 | 11 years | |
| Gunnar Gårdemyr | M | 65 | 3 years | |
| Christina Malmberg Hägerstrand | F | - | - | |
| Carl-Lars Spongberg | M | 79 |
Intervalor AB
Intervalor AB Investment ManagersFinance Intervalor AB is a private company that provides trustee services in Denmark and Norway. The company is based in Stockholm, Sweden. The Swedish company's focus is on managing assets for its clients. It has reference customers and can be contacted through its website. The company was founded in 1992 by Anders Lennart Bladh, who has been the CEO since then. | - |
| Ove Ewaldsson | M | 64 | 5 years | |
| Erik Bech-Jansen | M | 59 | - | |
| Charlotte Darth | F | 56 |
Intervalor AB
Intervalor AB Investment ManagersFinance Intervalor AB is a private company that provides trustee services in Denmark and Norway. The company is based in Stockholm, Sweden. The Swedish company's focus is on managing assets for its clients. It has reference customers and can be contacted through its website. The company was founded in 1992 by Anders Lennart Bladh, who has been the CEO since then. | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 40 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Anders Lennart Bladh
- Personal Network
